Home·Stocks·MRNA
Moderna, Inc. Common Stock

MRNA

XNAS

Moderna, Inc. Common Stock

Basic Materials · Biological Products, (No Diagnostic Substances)

$45.11
-0.26 (-0.57%)
15-min delayed

Drag to pan · Scroll to zoom · Hover for OHLC

Snapshot
Loading metrics…
About Moderna, Inc. Common Stock

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Employees
4,700
Country
US
IPO Date
2018-12-07
www.modernatx.com →
Recent News
Moderna's Post-COVID Collapse: Pipeline Risks & Cash Burn Explained
SeekingAlpha · 4h ago
The Zacks Analyst Blog Highlights Moderna, Merck and Vertex Pharmaceuticals
Yahoo · 5h ago
MRNA Q1 Deep Dive: International Partnerships and Pipeline Progress Offset Litigation Headwinds
Yahoo · 10h ago
Moderna (MRNA) Is Down 10.6% After Q1 Loss Widened On Settlement And EU Vaccine Wins – Has The Bull Case Changed?
Yahoo · 1d ago
A Look At Moderna (MRNA) Valuation After Q1 2026 Earnings And New Vaccine Approvals
Yahoo · 2d ago
Moderna Inc (MRNA) Q1 2026 Earnings Call Highlights: Strategic Growth Amidst Legal Challenges
Yahoo · 2d ago
Moderna, Inc. Q1 2026 Earnings Call Summary
Yahoo · 2d ago
These S&P500 stocks are moving in today's session
ChartMill · 2d ago
Analyst Ratings
Loading…
Financials
Loading SEC filings…
Insider Activity
Loading filings…
Related Stocks
Loading peers…
Ask AI about MRNABuild basket with MRNAScreener

Data is 15-minute delayed, for informational purposes only. Not investment advice. Prices via Massive.com consolidated feed. Fundamentals via FinancialModelingPrep. News via Finnhub.